A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices.


Updates from The Motley Fool

Latest updates on Johnson and Johnson from Fool.com.  The Fool has written over 2100 articles on Johnson and Johnson.
3 Stocks to Invest in Big Pharma

These drug kingpins are raking in the dough, which could lead to handsome returns for investors.



Stock Performance

View Interactive JNJ Charts
Sponsored by

Key Data Points

Primary metrics and data points about Johnson and Johnson.
Current Price: $121.66
Prev Close: $119.52
Open: $119.52
Bid: $121.62
Ask: $121.63
Day's Range: $119.48 - $121.90
52wk Range: $102.97 - $126.07
Volume: 7,438,547
Avg Vol 7,093,382
Market Cap: $331B
P/E (ttm): 20.16
EPS (ttm): $5.93
Div & Yield: $3.20 (2.7%)

Company Rating

What our community thinks about Johnson and Johnson.
CAPS Rating 5 out of 5
 
13637 Outperform
505 Underperform
CAPS All Stars
 
3206 Outperform
64 Underperform

How do you think Johnson and Johnson will perform against the market?



You pick for Johnson and Johnson is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Alex Gorsky, CEO

96% Approve

Based on 980 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Johnson and Johnson.

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers